149 related articles for article (PubMed ID: 29888320)
1. Targeting Poxvirus Decapping Enzymes and mRNA Decay to Generate an Effective Oncolytic Virus.
Burgess HM; Pourchet A; Hajdu CH; Chiriboga L; Frey AB; Mohr I
Mol Ther Oncolytics; 2018 Mar; 8():71-81. PubMed ID: 29888320
[TBL] [Abstract][Full Text] [Related]
2. Poxvirus-encoded decapping enzymes promote selective translation of viral mRNAs.
Cantu F; Cao S; Hernandez C; Dhungel P; Spradlin J; Yang Z
PLoS Pathog; 2020 Oct; 16(10):e1008926. PubMed ID: 33031446
[TBL] [Abstract][Full Text] [Related]
3. Vaccinia virus D10 has broad decapping activity that is regulated by mRNA splicing.
Ly M; Burgess HM; Shah SB; Mohr I; Glaunsinger BA
PLoS Pathog; 2022 Feb; 18(2):e1010099. PubMed ID: 35202449
[TBL] [Abstract][Full Text] [Related]
4. A Poxvirus Decapping Enzyme Colocalizes with Mitochondria To Regulate RNA Metabolism and Translation and Promote Viral Replication.
Cao S; Molina JA; Cantu F; Hernandez C; Yang Z
mBio; 2022 Jun; 13(3):e0030022. PubMed ID: 35435699
[TBL] [Abstract][Full Text] [Related]
5. Opposing Roles of Double-Stranded RNA Effector Pathways and Viral Defense Proteins Revealed with CRISPR-Cas9 Knockout Cell Lines and Vaccinia Virus Mutants.
Liu R; Moss B
J Virol; 2016 Sep; 90(17):7864-79. PubMed ID: 27334583
[TBL] [Abstract][Full Text] [Related]
6. Cellular 5'-3' mRNA exonuclease Xrn1 controls double-stranded RNA accumulation and anti-viral responses.
Burgess HM; Mohr I
Cell Host Microbe; 2015 Mar; 17(3):332-344. PubMed ID: 25766294
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a second vaccinia virus mRNA-decapping enzyme conserved in poxviruses.
Parrish S; Moss B
J Virol; 2007 Dec; 81(23):12973-8. PubMed ID: 17881455
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence-Based Activity Screening Assay Reveals Small Molecule Inhibitors of Vaccinia Virus mRNA Decapping Enzyme D9.
Bednarczyk M; Peters JK; Kasprzyk R; Starek J; Warminski M; Spiewla T; Mugridge JS; Gross JD; Jemielity J; Kowalska J
ACS Chem Biol; 2022 Jun; 17(6):1460-1471. PubMed ID: 35576528
[TBL] [Abstract][Full Text] [Related]
9. Structure of the poxvirus decapping enzyme D9 reveals its mechanism of cap recognition and catalysis.
Peters JK; Tibble RW; Warminski M; Jemielity J; Gross JD
Structure; 2022 May; 30(5):721-732.e4. PubMed ID: 35290794
[TBL] [Abstract][Full Text] [Related]
10. The D10 decapping enzyme of vaccinia virus contributes to decay of cellular and viral mRNAs and to virulence in mice.
Liu SW; Wyatt LS; Orandle MS; Minai M; Moss B
J Virol; 2014 Jan; 88(1):202-11. PubMed ID: 24155373
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the
Bravo Cruz AG; Han A; Roy EJ; Guzmán AB; Miller RJ; Driskell EA; O'Brien WD; Shisler JL
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490586
[TBL] [Abstract][Full Text] [Related]
12. Primary Human B Cells at Different Differentiation and Maturation Stages Exhibit Distinct Susceptibilities to Vaccinia Virus Binding and Infection.
Shepherd N; Lan J; Li W; Rane S; Yu Q
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292245
[TBL] [Abstract][Full Text] [Related]
13. RNA Polymerase Mutations Selected during Experimental Evolution Enhance Replication of a Hybrid Vaccinia Virus with an Intermediate Transcription Factor Subunit Replaced by the Myxoma Virus Ortholog.
Stuart CA; Zhivkoplias EK; Senkevich TG; Wyatt LS; Moss B
J Virol; 2018 Oct; 92(20):. PubMed ID: 30045995
[TBL] [Abstract][Full Text] [Related]
14. Vaccinia virus D10 protein has mRNA decapping activity, providing a mechanism for control of host and viral gene expression.
Parrish S; Resch W; Moss B
Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2139-44. PubMed ID: 17283339
[TBL] [Abstract][Full Text] [Related]
15. Monkeypox virus induces the synthesis of less dsRNA than vaccinia virus, and is more resistant to the anti-poxvirus drug, IBT, than vaccinia virus.
Arndt WD; White SD; Johnson BP; Huynh T; Liao J; Harrington H; Cotsmire S; Kibler KV; Langland J; Jacobs BL
Virology; 2016 Oct; 497():125-135. PubMed ID: 27467578
[TBL] [Abstract][Full Text] [Related]
16. Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus.
Arndt WD; Cotsmire S; Trainor K; Harrington H; Hauns K; Kibler KV; Huynh TP; Jacobs BL
J Virol; 2015 Oct; 89(20):10489-99. PubMed ID: 26246580
[TBL] [Abstract][Full Text] [Related]
17. Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells.
Kilinc MO; Ehrig K; Pessian M; Minev BR; Szalay AA
J Transl Med; 2016 Dec; 14(1):340. PubMed ID: 27993141
[TBL] [Abstract][Full Text] [Related]
18. Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps.
Kober C; Rohn S; Weibel S; Geissinger U; Chen NG; Szalay AA
J Transl Med; 2015 Jul; 13():216. PubMed ID: 26149494
[TBL] [Abstract][Full Text] [Related]
19. Naturally Occurring and Engineered Alphaviruses Sensitive to Double-Stranded-RNA-Activated Protein Kinase Show Restricted Translation in Mammalian Cells, Increased Sensitivity to Interferon, and Marked Oncotropism.
Toribio R; Díaz-López I; Berlanga JJ; Molina-Jiménez F; Majano P; Ventoso I
J Virol; 2020 Jan; 94(3):. PubMed ID: 31723025
[TBL] [Abstract][Full Text] [Related]
20. The Vaccinia Virus (VACV) B1 and Cellular VRK2 Kinases Promote VACV Replication Factory Formation through Phosphorylation-Dependent Inhibition of VACV B12.
Rico AB; Wang Z; Olson AT; Linville AC; Bullard BL; Weaver EA; Jones C; Wiebe MS
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]